|
?:authorAffiliation
|
-
[\'Twist Biopharma, Twist Bioscience, South San Francisco, CA, USA.\', \'Alamar Biosciences, Fremont, CA, USA.\', \'IAVI Neutralizing Antibody Center, Scripps Research, La Jolla, CA, USA.\', \'Neuroscience Research Institute, Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, CA, USA.\', \'Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, Maryland, USA.\', \'Integral Molecular, Philadelphia, PA,USA.\', \'Integrated BioTherapeutics, Inc. Rockville, MD, USA.\', \'Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.\', \'Department of Medicine, University of California San Diego, La Jolla, CA, USA.\', \'Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.\', \'Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}